Cardinal Health Reports First-quarter Results for Fiscal Year 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Cardinal Health (CAH) PT Lowered to $67 at Jefferies; Remains Sidelined
November 7, 2017 8:10 AM ESTJefferies lowered its price target on Cardinal Health (NYSE: CAH) to $67.00 (from $77.00) while maintaining a Hold rating following the company's earnings release. Despite missing consensus revenue by ~2.5% ($32.6B vs. $33.4B), CAH beat on earnings for the quarter as a result of better than expected... More
Cardinal Health (CAH) Tops Q1 EPS by 9c, Reaffirms FY18 EPS Guidance
November 6, 2017 6:47 AM ESTCardinal Health (NYSE: CAH) reported Q1 EPS of $1.09, $0.09 better than the analyst estimate of $1.00. Revenue for the quarter came in at $32.6 billion versus the consensus estimate of $33.48 billion.
The company reaffirms its fiscal year 2018 guidance range for non-GAAP diluted EPS of $4.85 to $5.10.
For... More
